List of Tables
Table 1. Global Parkinson Disease Drug Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson Disease Drug Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 8. Global Parkinson Disease Drug Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 9. Global Parkinson Disease Drug Market Size by Region (US$ Million), 2021–2026
Table 10. Global Parkinson Disease Drug Market Share by Region (2021–2026)
Table 11. Global Parkinson Disease Drug Forecasted Market Size by Region (US$ Million), 2027–2032
Table 12. Global Parkinson Disease Drug Market Share by Region (2027–2032)
Table 13. Parkinson Disease Drug Market Trends
Table 14. Parkinson Disease Drug Market Drivers
Table 15. Parkinson Disease Drug Market Challenges
Table 16. Parkinson Disease Drug Market Restraints
Table 17. Global Parkinson Disease Drug Revenue by Players (US$ Million), 2021–2026
Table 18. Global Parkinson Disease Drug Market Share by Players (2021–2026)
Table 19. Global Top Parkinson Disease Drug Players by Tier (Tier 1, Tier 2, and Tier 3), based on Parkinson Disease Drug Revenue, 2025
Table 20. Ranking of Global Top Parkinson Disease Drug Companies by Revenue (US$ Million) in 2025
Table 21. Global 5 Largest Players Market Share by Parkinson Disease Drug Revenue (CR5 and HHI), 2021–2026
Table 22. Global Key Players of Parkinson Disease Drug, Headquarters and Area Served
Table 23. Global Key Players of Parkinson Disease Drug, Products and Applications
Table 24. Global Key Players of Parkinson Disease Drug, Date of General Availability (GA)
Table 25. Mergers and Acquisitions, Expansion Plans
Table 26. Global Parkinson Disease Drug Market Size by Type (US$ Million), 2021–2026
Table 27. Global Parkinson Disease Drug Revenue Market Share by Type (2021–2026)
Table 28. Global Parkinson Disease Drug Forecasted Market Size by Type (US$ Million), 2027–2032
Table 29. Global Parkinson Disease Drug Revenue Market Share by Type (2027–2032)
Table 30. Global Parkinson Disease Drug Market Size by Application (US$ Million), 2021–2026
Table 31. Global Parkinson Disease Drug Revenue Market Share by Application (2021–2026)
Table 32. Global Parkinson Disease Drug Forecasted Market Size by Application (US$ Million), 2027–2032
Table 33. Global Parkinson Disease Drug Revenue Market Share by Application (2027–2032)
Table 34. North America Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. North America Parkinson Disease Drug Market Size by Country (US$ Million), 2021–2026
Table 36. North America Parkinson Disease Drug Market Size by Country (US$ Million), 2027–2032
Table 37. Europe Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 38. Europe Parkinson Disease Drug Market Size by Country (US$ Million), 2021–2026
Table 39. Europe Parkinson Disease Drug Market Size by Country (US$ Million), 2027–2032
Table 40. Asia-Pacific Parkinson Disease Drug Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 41. Asia-Pacific Parkinson Disease Drug Market Size by Region (US$ Million), 2021–2026
Table 42. Asia-Pacific Parkinson Disease Drug Market Size by Region (US$ Million), 2027–2032
Table 43. Latin America Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Latin America Parkinson Disease Drug Market Size by Country (US$ Million), 2021–2026
Table 45. Latin America Parkinson Disease Drug Market Size by Country (US$ Million), 2027–2032
Table 46. Middle East & Africa Parkinson Disease Drug Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 47. Middle East & Africa Parkinson Disease Drug Market Size by Country (US$ Million), 2021–2026
Table 48. Middle East & Africa Parkinson Disease Drug Market Size by Country (US$ Million), 2027–2032
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck Parkinson Disease Drug Product
Table 52. Merck Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 53. Merck Recent Development
Table 54. Akorn Company Details
Table 55. Akorn Business Overview
Table 56. Akorn Parkinson Disease Drug Product
Table 57. Akorn Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 58. Akorn Recent Development
Table 59. GSK Company Details
Table 60. GSK Business Overview
Table 61. GSK Parkinson Disease Drug Product
Table 62. GSK Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 63. GSK Recent Development
Table 64. Novartis Company Details
Table 65. Novartis Business Overview
Table 66. Novartis Parkinson Disease Drug Product
Table 67. Novartis Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 68. Novartis Recent Development
Table 69. Boehringer Ingelheim Company Details
Table 70. Boehringer Ingelheim Business Overview
Table 71. Boehringer Ingelheim Parkinson Disease Drug Product
Table 72. Boehringer Ingelheim Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 73. Boehringer Ingelheim Recent Development
Table 74. Teva Pharmaceutical Company Details
Table 75. Teva Pharmaceutical Business Overview
Table 76. Teva Pharmaceutical Parkinson Disease Drug Product
Table 77. Teva Pharmaceutical Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 78. Teva Pharmaceutical Recent Development
Table 79. Abbvie Company Details
Table 80. Abbvie Business Overview
Table 81. Abbvie Parkinson Disease Drug Product
Table 82. Abbvie Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 83. Abbvie Recent Development
Table 84. Kyowa Hakko Kirin Pharma Company Details
Table 85. Kyowa Hakko Kirin Pharma Business Overview
Table 86. Kyowa Hakko Kirin Pharma Parkinson Disease Drug Product
Table 87. Kyowa Hakko Kirin Pharma Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 88. Kyowa Hakko Kirin Pharma Recent Development
Table 89. Astellas Pharma Company Details
Table 90. Astellas Pharma Business Overview
Table 91. Astellas Pharma Parkinson Disease Drug Product
Table 92. Astellas Pharma Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 93. Astellas Pharma Recent Development
Table 94. Desitin Arzneimittel Company Details
Table 95. Desitin Arzneimittel Business Overview
Table 96. Desitin Arzneimittel Parkinson Disease Drug Product
Table 97. Desitin Arzneimittel Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 98. Desitin Arzneimittel Recent Development
Table 99. Endo Pharmaceuticals Company Details
Table 100. Endo Pharmaceuticals Business Overview
Table 101. Endo Pharmaceuticals Parkinson Disease Drug Product
Table 102. Endo Pharmaceuticals Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 103. Endo Pharmaceuticals Recent Development
Table 104. F.Hoffmann-La Roche Company Details
Table 105. F.Hoffmann-La Roche Business Overview
Table 106. F.Hoffmann-La Roche Parkinson Disease Drug Product
Table 107. F.Hoffmann-La Roche Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 108. F.Hoffmann-La Roche Recent Development
Table 109. H.Lundbeck Company Details
Table 110. H.Lundbeck Business Overview
Table 111. H.Lundbeck Parkinson Disease Drug Product
Table 112. H.Lundbeck Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 113. H.Lundbeck Recent Development
Table 114. Valeant Company Details
Table 115. Valeant Business Overview
Table 116. Valeant Parkinson Disease Drug Product
Table 117. Valeant Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 118. Valeant Recent Development
Table 119. Apokyn Company Details
Table 120. Apokyn Business Overview
Table 121. Apokyn Parkinson Disease Drug Product
Table 122. Apokyn Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 123. Apokyn Recent Development
Table 124. Orion Company Details
Table 125. Orion Business Overview
Table 126. Orion Parkinson Disease Drug Product
Table 127. Orion Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 128. Orion Recent Development
Table 129. Stada Arzneimittel Company Details
Table 130. Stada Arzneimittel Business Overview
Table 131. Stada Arzneimittel Parkinson Disease Drug Product
Table 132. Stada Arzneimittel Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 133. Stada Arzneimittel Recent Development
Table 134. US WorldMeds Company Details
Table 135. US WorldMeds Business Overview
Table 136. US WorldMeds Parkinson Disease Drug Product
Table 137. US WorldMeds Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 138. US WorldMeds Recent Development
Table 139. Bausch Health Company Details
Table 140. Bausch Health Business Overview
Table 141. Bausch Health Parkinson Disease Drug Product
Table 142. Bausch Health Revenue in Parkinson Disease Drug Business (US$ Million), 2021–2026
Table 143. Bausch Health Recent Development
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
Table 147. Authors List of This Report
List of Figures
Figure 1. Parkinson Disease Drug Picture
Figure 2. Global Parkinson Disease Drug Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Parkinson Disease Drug Market Share by Type: 2025 vs 2032
Figure 4. Sinemet-CR Features
Figure 5. Trastal Features
Figure 6. Madopar Features
Figure 7. COMT Inhibitor Features
Figure 8. Other Features
Figure 9. Global Parkinson Disease Drug Market Size by Application (US$ Million), 2021–2032
Figure 10. Global Parkinson Disease Drug Market Share by Application: 2025 vs 2032
Figure 11. Under 40 Years Old Case Studies
Figure 12. 40-65 Years Old Case Studies
Figure 13. Above 65 Years Old Case Studies
Figure 14. Parkinson Disease Drug Report Years Considered
Figure 15. Global Parkinson Disease Drug Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 16. Global Parkinson Disease Drug Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Parkinson Disease Drug Market Share by Region: 2025 vs 2032
Figure 18. Global Parkinson Disease Drug Market Share by Players in 2025
Figure 19. Global Parkinson Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Parkinson Disease Drug Revenue in 2025
Figure 21. North America Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. North America Parkinson Disease Drug Market Share by Country (2021–2032)
Figure 23. United States Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Canada Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. Europe Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Europe Parkinson Disease Drug Market Share by Country (2021–2032)
Figure 27. Germany Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. France Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. U.K. Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Italy Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Russia Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Ireland Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Asia-Pacific Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Asia-Pacific Parkinson Disease Drug Market Share by Region (2021–2032)
Figure 35. China Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Japan Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. South Korea Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Southeast Asia Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. India Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Australia & New Zealand Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Latin America Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Latin America Parkinson Disease Drug Market Share by Country (2021–2032)
Figure 43. Mexico Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Brazil Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Middle East & Africa Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Middle East & Africa Parkinson Disease Drug Market Share by Country (2021–2032)
Figure 47. Israel Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Saudi Arabia Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. UAE Parkinson Disease Drug Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Merck Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 51. Akorn Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 52. GSK Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 53. Novartis Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 55. Teva Pharmaceutical Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 56. Abbvie Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 57. Kyowa Hakko Kirin Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 58. Astellas Pharma Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 59. Desitin Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 60. Endo Pharmaceuticals Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 61. F.Hoffmann-La Roche Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 62. H.Lundbeck Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 63. Valeant Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 64. Apokyn Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 65. Orion Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 66. Stada Arzneimittel Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 67. US WorldMeds Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 68. Bausch Health Revenue Growth Rate in Parkinson Disease Drug Business (2021–2026)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
